Development of poly(ortho esters): a historical overview.

Area of Science:

• Polymer chemistry
• Biomaterials science
• Drug delivery systems

Background:

• Poly(ortho esters) are a class of bioerodible polymers with significant potential in drug delivery.
• Three distinct synthetic routes for poly(ortho esters) have been established, originating from Alza Corporation and SRI International.
• These polymers are characterized by their acid-labile ortho ester bonds, enabling controlled degradation.

Observation:

• The first poly(ortho ester) system, developed at Alza Corporation, is synthesized via transesterification of a diol and diethoxytetrahydrofuran, marketed as Alzamer.
• SRI International developed two systems: one by adding polyols to a diketene acetal, and another through transesterification of a triol and an ortho ester followed by self-condensation.
• The key characteristic enabling tunable drug release is the acid sensitivity of the polymer backbone.

Findings:

• The acid sensitivity of poly(ortho esters) is crucial for their application in drug delivery.
• By incorporating acidic or basic excipients, the degradation rate of the polymer matrix can be precisely controlled.
• This control allows for the design of drug delivery devices with predetermined lifetimes, ranging from hours to several months.

Implications:

• Poly(ortho esters) offer a versatile platform for developing advanced drug delivery systems with tailored release profiles.
• The ability to modulate degradation rates through excipient selection provides a significant advantage for chronic and acute therapeutic applications.
• Further research into poly(ortho ester) formulations could lead to improved patient compliance and therapeutic outcomes.